Results 181 to 190 of about 5,633 (190)

Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment

Joint Bone Spine, 2016
Thomas Bardin, Gérard Chales, Tristan Pascart   +2 more
exaly  

Febuxostat

Reactions Weekly, 2023
openaire   +1 more source

A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout

Seminars in Arthritis and Rheumatism, 2013
Natasha Wiebe, Lisa Tjosvold, Joanne Homik   +2 more
exaly  

The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia – A systematic review and meta-analysis

Nutrition, Metabolism and Cardiovascular Diseases, 2019
Cheng-Wei Liu, Chia-Cheng Lee, Wen-Yi Shau   +2 more
exaly  

An allopurinol‐controlled, multicenter, randomized, double‐blind, parallel between‐group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia

International Journal of Rheumatic Diseases, 2014
Jieruo Gu, Xiangpei Li, Anbin Huang
exaly  

Febuxostat suppressed renal ischemia–reperfusion injury via reduced oxidative stress

Biochemical and Biophysical Research Communications, 2012
Noritaka Kawada, Jun-Ya Kaimori, Harumi Kitamura   +2 more
exaly  

Pharmacokinetic Interactions of Concomitant Administration of Febuxostat and NSAIDs

Journal of Clinical Pharmacology, 2006
Reza Khosravan, Nancy Joseph-Ridge, Laurent Vernillet   +2 more
exaly  

Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner

Naunyn-Schmiedeberg's Archives of Pharmacology, 2015
Alaa N A Fahmi, George S G Shehatou, Abdelhadi M Shebl   +2 more
exaly  

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

Life Sciences, 2005
exaly  

A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia

International Journal of Rheumatic Diseases, 2015
Xiangyang Liu, Yongde Peng, Jianqin Wang   +2 more
exaly